Maternal antibody induced by recombinant gp85 protein vaccine adjuvanted with CpG-ODN protects against ALV-J early infection in chickens

Vaccine

Volumn 31, Issue 51, 2013, Pages 6144-6149

  Dou, Wenwen ^a   Li, Hongmei ^a   Cheng, Ziqiang ^a   Zhao, Peng ^a   Liu, Jianzhu ^a   Cui, Zhizhong ^a   Liu, Haigang ^a   Jing, Weifang ^a   Guo, Huijun ^a  

^a SHANDONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

CpG ODN; Immunoprotection; Maternal antibody; Recombinant gp85 protein; Subgroup J avian leukosis virus (ALV J)

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; MATERNAL ANTIBODY; RECOMBINANT GP85 PROTEIN VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; AVIAN LEUKOSIS ONCOVIRUS; CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; ESCHERICHIA COLI; INFECTION PREVENTION; J AVIAN LEUKOSIS ONCOVIRUS INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE CULTURE; VACCINATION; VIRUS INFECTION; ZYGOTE;

CPG-ODN; IMMUNOPROTECTION; MATERNAL ANTIBODY; RECOMBINANT GP85 PROTEIN; SUBGROUP J AVIAN LEUKOSIS VIRUS (ALV-J);

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; AVIAN LEUKOSIS; AVIAN LEUKOSIS VIRUS; CHICKENS; ESCHERICHIA COLI; FREUND'S ADJUVANT; GENE EXPRESSION; HISTOCYTOCHEMISTRY; IMMUNITY, MATERNALLY-ACQUIRED; INJECTIONS, INTRAMUSCULAR; OLIGODEOXYRIBONUCLEOTIDES; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; VIRAL PROTEINS; VIRAL VACCINES; VIREMIA;

EID: 84888430876     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.058     Document Type: Article

References (26)

1. Payne L.N., Gillespie A.M., Howes K. Recovery of acutely transforming viruses from myeloid leukosis induced by the HPRS-103 strain of avian leukosis virus. Avian Dis 1993, 37:438-450.
2. Witter R. Avian tumor viruses: persistent and evolving pathogens. Acta Vet Hung 1997, 45:261-266.
3. Fadly A.M., Smith E.J. Isolation and some characteristics of an isolate associated with myeloid leukosis in meat-type chickens in the United States. Avian Dis 1999, 43:391-400.
4. Du Y., Cui Z.Z., Qin A.J. Subgroup J of avian leukosis viruses in China. China Poult Sci 1999, 3:1-4.
5. Chen Z., Zhang L., Liu S., Zhang L., Cui Z. Emerging of avian leukosis virus subgroup J in a flock of Chinese local breed. Acta Microbiol Sin 2005, 45:584-587.
6. Sun S.H., Cui Z.Z. Epidemiological and pathological studies of subgroup J avian leukosis virus infections in Chinese local "yellow" chickens. Avian Pathol 2007, 36:221-226.
7. Cheng Z., Liu J., Cui Z., Zhang L. Tumors associated with avian leukosis virus subgroup J in layer hens during 2007 to 2009 in China. J Vet Med Sci 2010, 72:1027-1033.
8. Gao Y.L., Qin L.T., Pan W., Wang Y.Q., Qi X.L., Gao H.L., et al. Subgroup J avian leukosis virus in layer flocks in China. Emerg Infect Dis 2010, 16:1637-1638.
9. Lai H.Z., Zhang H.N., Ning Z.Y., Chen R.A., Zhang W.Z., Qin A.J., et al. Isolation and characterization of emerging subgroup J avian leukosis virus associated with hemangioma in egg-type chickens. Vet Microbiol 2011, 3:1-9.
10. Vleugels B., Ververken C., Goddeeris B.M. Stimulatory effect of CpG sequences on humoral response in chickens. Poult Sci 2002, 81:1317-1321.
11. Wang X., Jiang P., Deen S., Wu J., Liu X., Xu J. Efficacy of DNA vaccines against infectious bursal disease virus in chickens enhanced by coadministration with CpG oligodeoxynucleotide. Avian Dis 2003, 47:1305-1312.
12. Dalloul R.A., Lillehoj H.S., Klinman D.M., Ding X., Min W., Heckert R.A., et al. In ovo administration of CpG oligodeoxynucleotides and the recombinant microneme protein MIC2 protects against Eimeria infections. Vaccine 2005, 23:3108-3113.
13. Mahmood M.S., Siddique M., Hussain I., Khan A., Mansoor M.K. Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of highly virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide. Vaccine 2006, 24:4838-4846.
14. Cui Z.Z., Guo H.J., Sun S.H. Prevalence situation and prevention and control of avian leukosis. Chin J Vet Drug 2009, 43:37-41.
15. Zhang J.Y., Cui Z.Z., Ding J.B., Jiang S.J. Construction of infectious clone of subgroup J avian leukosis virus strain NX0101 and its pathogenicity. Acta Microbiol Sin 2005, 45:437-440.
16. Sun B.B., Cui Z.Z., Zhang Q.C., Lou B.H. Dynamics of viremia and antibody responses in chickens inoculated with ALV-J. Sci Agric Sin 2009, 42:4069-4076.
17. Venugopal K., Smith L.M., Howes K., Payne L.N. Antigenic variants of J subgroup avian leukosis virus: sequence analysis reveals multiple changes in the env gene. J Gen Virol 1998, 79:757-766.
18. Silva R.F., Fadly A.M., Hunt H.D. Hypervariability in the envelope genes of subgroup J avian leukosis viruses obtained from different farms in the United States. Virology 2000, 272:106-111.
19. Pandiri A.R., Mays J.K., Silva R.F., Hunt H.D., Reed W.M., Fadly A.M. Subgroup J avian leukosis virus neutralizing antibody escape variants contribute to viral persistence in meat-type chickens. Avian Dis 2010, 54:848-856.
20. Wang X.P., Qun K., Qin A.J., Shen H.Y., Wang P.P., Jin W.J., et al. Recombinant avian leukosis viruses of subgroup J isolated from field infected commercial layer chickens with hemangioma and myeloid leukosis possess an insertion in the E element. Vet Res Commun 2010, 34:619-632.
21. Pan W., Gao Y.L., Qin L.T., Ni W., Liu Z.S., Yun B.L., et al. Genetic diversity and phylogenetic analysis of glycoprotein GP85 of ALV-J isolates from Mainland China between 1999 and 2010: coexistence of two extremely different subgroups in layers. Vet Microbiol 2012, 156:205-212.
22. Stills H.F. Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants. ILAR J 2005, 46:280-293.
23. Davis H.L., Weeratna R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M., et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 1998, 160:870-876.
24. Liu Y., Luo X., Yang C.T., Yu S.K., Xu H.L. Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice. Vaccine 2011, 29:5778-5784.
25. Mutwiri G., den Hurk S.D.L., Babiuk L.A. Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides. Adv Drug Deliv Rev 2009, 61:226-232.
26. Mutwiri G., Benjamin P., Soita H., Babiuk L.A. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen. Vaccine 2008, 26:2680-2688.